Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Therapeutic cancer vaccines
Cornelis J.M. Melief, … , Ferry Ossendorp, Sjoerd H. van der Burg
Cornelis J.M. Melief, … , Ferry Ossendorp, Sjoerd H. van der Burg
Published July 27, 2015
Citation Information: J Clin Invest. 2015;125(9):3401-3412. https://doi.org/10.1172/JCI80009.
View: Text | PDF
Review Series Article has an altmetric score of 23

Therapeutic cancer vaccines

  • Text
  • PDF
Abstract

The clinical benefit of therapeutic cancer vaccines has been established. Whereas regression of lesions was shown for premalignant lesions caused by HPV, clinical benefit in cancer patients was mostly noted as prolonged survival. Suboptimal vaccine design and an immunosuppressive cancer microenvironment are the root causes of the lack of cancer eradication. Effective cancer vaccines deliver concentrated antigen to both HLA class I and II molecules of DCs, promoting both CD4 and CD8 T cell responses. Optimal vaccine platforms include DNA and RNA vaccines and synthetic long peptides. Antigens of choice include mutant sequences, selected cancer testis antigens, and viral antigens. Drugs or physical treatments can mitigate the immunosuppressive cancer microenvironment and include chemotherapeutics, radiation, indoleamine 2,3-dioxygenase (IDO) inhibitors, inhibitors of T cell checkpoints, agonists of selected TNF receptor family members, and inhibitors of undesirable cytokines. The specificity of therapeutic vaccination combined with such immunomodulation offers an attractive avenue for the development of future cancer therapies.

Authors

Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp, Sjoerd H. van der Burg

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Total
Citations: 14 26 28 30 45 42 30 26 29 24 2 296
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (296)

Title and authors Publication Year
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Gawande MS, Zade N, Kumar P, Gundewar S, Weerarathna IN, Verma P
Molecular Biomedicine 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site
Roberti MP, Charoentong P, Lyu Y, Meyer M, Eichmüller SB, Schmidt P, Momburg F, Cetin M, Hartmann F, Valous NA, Stenzinger A, Michel L, Lichter P, Schneeweiss A, Thewes V, Fremd C, Zörnig I, Jäger D
Oncoimmunology 2025
An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B α1/2 shedding
Wang R, Wu J, Lin Y, Xiao Y, Yang B, Yao S, Pan T, Fu Z, Li S, Wang C, Zhu Y
Cell Reports Medicine 2025
The Bright Future of mRNA as a Therapeutic Molecule
Vélez DE, Torres BL, Hernández G
Genes 2025
Advances in cancer nanovaccines: a focus on colorectal cancer
Ghazizadeh Y, Salehi Shadkami H, Madani F, Niknam S, Adabi M
Nanomedicine 2025
Exosome-based cancer vaccine: a cell-free approach.
Sonar S, Das A, Kalele K, Subramaniyan V
Molecular biology reports 2025
Immune Cell Homing Hydrogels for Cancer Immunotherapy.
Han J, Wang H
Methods in molecular biology (Clifton, N.J.) 2025
Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool.
Nisar MF, Yan T, Cai Y, Wan C
Probiotics and antimicrobial proteins 2025
Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines
Hushmandi K, Imani Fooladi AA, Reiter RJ, Farahani N, Liang L, Aref AR, Nabavi N, Alimohammadi M, Liu L, Sethi G
Experimental Hematology & Oncology 2025
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Gomari MM, Ghantabpour T, Pourgholam N, Rostami N, Hatfield SM, Namazifar F, Abkhiz S, Eslami SS, Ramezanpour M, Darestanifarahani M, Astsaturov I, Bencherif\u2009 SA
Cancer Communications 2025
Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
Jiang M, Li J, Wei J, Yang X, Wang W
Frontiers in Oncology 2025
Efficacy of Using Dendritic Cells in the Treatment of Prostate Cancer: A Systematic Review
Pacheco HF, Fernandes JL, Dias FC, Deus MC, Ribeiro DL, Michelin MA, Gomes ML
International Journal of Molecular Sciences 2025
L-type association between magnesium intake and human papillomavirus infection in US adult women: based on NHANES 2003–2016 data
Chen H, Chen X, Chen Y, Tang L, Shi WJ, Ou YH
Frontiers in Nutrition 2025
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer
Fan Z, Wang Z, Zhang H, Zhang H, Zhao R, Zhu S, Liu X
Cancer Immunology, Immunotherapy : CII 2025
Second-generation checkpoint inhibitors synergize with a cancer vaccine in preclinical models
William Becker, Purevdorj Olkhanud, Noriko Seishima, Paloma A Moreno, Hoyoung M. Maeng, Jay Berzofsky
Journal for ImmunoTherapy of Cancer 2024
Vaccines: a promising therapy for myelodysplastic syndrome
Gera K, Chauhan A, Castillo P, Rahman M, Mathavan A, Mathavan A, Oganda-Rivas E, Elliott L, Wingard JR, Sayour EJ
Journal of Hematology & Oncology 2024
LADS: A Powerful Vaccine Platform for Cancer Immunotherapy and Prevention
Changyong Cheng, Jing Sun, Xin Jiang, Jing Xia, Yue Han, Jing Wang, Mianmian Chen, Jiali Xu, Simin Deng, Houhui Song
BMC biology 2024
Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold.
Li X, Liang X, Fu W, Luo R, Zhang M, Kou X, Zhang Y, Li Y, Huang D, You Y, Wu Q, Gong C
Bioactive Materials 2024
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Lekan AA, Weiner LM
Cancers 2024
Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review
Gonçalves CA, Pereira-da-Silva G, Silveira RC, Mayer PC, Zilly A, Lopes-Júnior LC
Cancers 2024
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade.
Moghassemi S, Dadashzadeh A, Sousa MJ, Vlieghe H, Yang J, León-Félix CM, Amorim CA
Bioactive Materials 2024
Truncated PD1 Engineered Gas‐Producing Extracellular Vesicles for Ultrasound Imaging and Subsequent Degradation of PDL1 in Tumor Cells
Zhang S, Liang Y, Ji P, Zheng R, Lu F, Hou G, Yang G, Yuan L
Advanced Science 2024
Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development.
Zdrehus R, Delcea C, Mocan L
Pharmaceutics 2024
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis
Tiwari A, Alcover K, Carpenter E, Thomas K, Krum J, Nissen A, Van Decar S, Smolinsky T, Valdera F, Vreeland T, Lacher M, Del Priore G, Williams W, Stojadinovic A, Peoples G, Clifton G
Human Vaccines & Immunotherapeutics 2024
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L
Clinical and Translational Medicine 2024
Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines
Amhis N, Carignan J, Tai LH
2024
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1
Taylor JL, Kokolus KM, Basse PH, Filderman JN, Cosgrove CE, Watkins SC, Gambotto A, Lowe DB, Edwards RP, Kalinski P, Storkus WJ
Human vaccines 2024
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective
Liu D, Liu L, Li X, Wang S, Wu G, Che X
Vaccines 2024
Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations
Phan T, Fan D, Melstrom LG
Current Oncology 2024
Boron Neutron Capture Therapy‐Derived Extracellular Vesicles via DNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy
Lv L, Zhang J, Wang Y, Liang H, Liu Q, Hu F, Li H, Su W, Zhang J, Chen R, Chen Z, Wang Z, Li J, Yan R, Yang M, Chang Y, Li J, Liang T, Xing G, Chen K
Advanced Science 2024
Emerging Cancer Immunotherapies: Cutting-Edge Advances and Innovations in Development
Maccagno M, Tapparo M, Saccu G, Rumiano L, Kholia S, Silengo L, Herrera Sanchez MB
Medical Sciences 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.
Huber F, Arnaud M, Stevenson BJ, Michaux J, Benedetti F, Thevenet J, Bobisse S, Chiffelle J, Gehert T, Müller M, Pak H, Krämer AI, Altimiras ER, Racle J, Taillandier-Coindard M, Muehlethaler K, Auger A, Saugy D, Murgues B, Benyagoub A, Gfeller D, Laniti DD, Kandalaft L, Rodrigo BN, Bouchaab H, Tissot S, Coukos G, Harari A, Bassani-Sternberg M
Nature biotechnology 2024
CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications
Feng X, Li Z, Liu Y, Chen D, Zhou Z
Experimental Hematology & Oncology 2024
Short Peptides as Powerful Arsenal for Smart Fighting Cancer
Bojarska J, Wolf WM
Cancers 2024
Exosome therapeutics for non-small cell lung cancer tumorigenesis
Orooji N, Fadaee M, Kazemi T, Yousefi B
Cancer Cell International 2024
Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T-Cell Epitopes.
Wang AZ, Brink HJ, Bouma RG, Affandi AJ, Nijen Twilhaar MK, Heijnen DAM, van Elk J, Maaskant JJ, Konijn VAL, Stolwijk JGC, Kalay H, Olesek K, van Kooyk Y, van der Schoot JMS, Bentlage AEH, Scheeren FA, Verdoes M, Vidarsson G, Kuijl CP, den Haan JMM
Bioconjugate chemistry 2024
Unlocking cancer vaccine potential: What are the key factors?
Grant M, Ni Lee L, Chinnakannan S, Tong O, Kwok J, Cianci N, Tillman L, Saha A, Pereira Almeida V, Leung C
Human Vaccines & Immunotherapeutics 2024
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Han J, Wang H
Experimental & Molecular Medicine 2024
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy
Keshari S, Shavkunov AS, Miao Q, Saha A, Minowa T, Molgora M, Williams CD, Chaib M, Highsmith AM, Pineda JE, Alekseev S, Alspach E, Hu KH, Colonna M, Pauken KE, Chen K, Gubin MM
Cell reports 2024
Prodrugs of paclitaxel improve in-situ photo-vaccination
Giram P, Bist G, Woo S, Wohlfert E, Pili R, You Y
Photochemistry and photobiology 2024
Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model
Krotova K, Kuoch (Yoshitomi) H, Caine C, Aslanidi G
2023
Dynamic Covalent Dextran Hydrogels as Injectable, Self-Adjuvating Peptide Vaccine Depots
Fan B, Torres García D, Salehi M, Webber MJ, van Kasteren SI, Eelkema R
ACS chemical biology 2023
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
Loukinov D, Anderson AL, Mkrtichyan M, Ghochikyan A, Rivero-Hinojosa S, Tucker J, Lobanenkov V, Agadjanyan MG, Nelson EL
International journal of molecular sciences 2023
Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen
Pifferi C, Aguinagalde L, Ruiz-de-Angulo A, Sacristán N, Baschirotto PT, Poveda A, Jiménez-Barbero J, Anguita J, Fernández-Tejada A
Chemical Science 2023
Melanoma stem cell vaccine induces effective tumor immunity against melanoma
Yin Q, Zhao N, Chang Y, Dong M, Xu M, Xu W, Jin HF, Liu W, Xu N
Human Vaccines & Immunotherapeutics 2023
Epigenetically programmed resistance to chemo- and immuno-therapies.
Walker RR, Rentia Z, Chiappinelli KB
Advances in cancer research 2023
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
Magré L, Verstegen MMA, Buschow S, van der Laan LJW, Peppelenbosch M, Desai J
Journal for ImmunoTherapy of Cancer 2023
Modulation of T cell function and survival by the tumor microenvironment
Mani N, Andrews D, Obeng RC
Frontiers in Cell and Developmental Biology 2023
Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review.
Danaeifar M, Negahdari B, Eslam HM, Zare H, Ghanaat M, Koushali SS, Malekshahi ZV
Biotechnology Letters 2023
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
Dillman RO, Nistor GI, Keirstead HS
Human Vaccines & Immunotherapeutics 2023
An Overview of Nanomaterial Applications in Pharmacology
Roy M, Roy A, Rustagi S, Pandey N
BioMed Research International 2023
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Czajka-Francuz P, Prendes MJ, Mankan A, Quintana Á, Pabla S, Ramkissoon S, Jensen TJ, Peiró S, Severson EA, Achyut BR, Vidal L, Poelman M, Saini KS
Frontiers in Oncology 2023
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine.
Han J, Bhatta R, Liu Y, Bo Y, Elosegui-Artola A, Wang H
Nature Communications 2023
L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells
Heo Y, Ko E, Park S, Park SO, Ahn BC, Yum JS, Chun E
Cancers 2023
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma.
Tojjari A, Saeed A, Singh M, Cavalcante L, Sahin IH, Saeed A
Human vaccines 2023
Peptide-based vaccine for cancer therapies.
Buonaguro L, Tagliamonte M
Frontiers in immunology 2023
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo
Jansen DT, de Beijer MT, Luijten RJ, Kwappenberg K, Wiekmeijer AS, Kessler AL, Pieterman RF, Bouzid R, Krebber WJ, de Man RA, Melief CJ, Buschow SI
Frontiers in immunology 2023
Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment
Ramirez F, Zambrano A, Hennis R, Holland N, Lakshmanaswamy R, Chacon J
Human vaccines 2023
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines
Gupta S, Pellett S
Toxins 2023
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Liu D, Che X, Wang X, Ma C, Wu G
Pharmaceuticals 2023
Lipid-polymer hybrid nanoparticles utilize B cells and dendritic cells to elicit distinct antigen-specific CD4+ and CD8+ T cell responses
Zhang MH, Scotland BL, Jiao Y, Slaby EM, Truong N, Cottingham AL, Stephanie G, Szeto GL, Pearson RM
2023
Harnessing allogeneic CD4+ T cells to reinvigorate host endogenous antitumor immunity
Mochizuki K
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 2023
Evaluation of Seroconversion Rate Following SARS COV 2 Vaccination in Health Care Workers at Shahid Beheshti University of Medical Sciences.
Alavi M, Mousavi M, Jazayeri M, Ebadifar A
Avicenna journal of medical biotechnology 2023
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.
Gu J, Chen J, Xiang S, Zhou X, Li J
Journal of Advanced Research 2023
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Anayyat U, Ahad F, Muluh TA, Zaidi SA, Usmani F, Yang H, Li M, Hassan HA, Wang X
Breast cancer : targets and therapy 2023
Cancer Vaccines in the Immunotherapy Era: Promise and Potential
Verma C, Pawar VA, Srivastava S, Tyagi A, Kaushik G, Shukla SK, Kumar V
Human vaccines 2023
Overlapping and Distinct Mechanisms of Effective Neoantigen Cancer Vaccines and Immune Checkpoint Therapy
Keshari S, Shavkunov AS, Miao Q, Saha A, Williams CD, Highsmith AM, Pineda JE, Alspach E, Hu KH, Pauken KE, Chen K, Gubin MM
2023
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.
Kumar V, Mahato RI
Cancer Letters 2023
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
D Chai, D Qiu, X Shi, J Ding, N Jiang, Z Zhang, J Wang, J Yang, P Xiao, G Wang, J Zheng
Molecular Therapy — Oncolytics 2022
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
M Khelil, Y Godet, S Abdeljaoued, C Borg, O Adotévi, R Loyon
Cancers 2022
Oncolytic Vaccinia Virus in Lung Cancer Vaccines
C Truong, S Yoo
Human vaccines 2022
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy
L Marconato, A Melacarne, M Aralla, S Sabattini, L Tiraboschi, V Ferrari, O Zeira, A Balboni, E Faroni, D Guerra, L Pisoni, E Ghezzi, L Pettinari, M Rescigno
Cancers 2022
Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
M Twilhaar, L Czentner, R Bouma, K Olesek, J Grabowska, A Wang, A Affandi, S Belt, H Kalay, C van Nostrum, Y van Kooyk, G Storm, J den Haan
Frontiers in immunology 2022
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
J Liu, M Fu, M Wang, D Wan, Y Wei, X Wei
Journal of Hematology & Oncology 2022
Development of Peptide-Based Vaccines for Cancer
N Abd-Aziz, C Poh, X Ding
Journal of Oncology 2022
mRNA cancer vaccines: Advances, trends and challenges
Q He, H Gao, D Tan, H Zhang, J Wang
Acta pharmaceutica Sinica. B 2022
Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
A Kiessling, K Ramanathan, O Nilsson, L Notari, S Renken, R Kiessling, H Grönlund, S Wickström
Frontiers in Oncology 2022
Photodynamic Therapy: Methods and Protocols
M Broekgaarden, H Zhang, M Korbelik, M Hamblin, M Heger
2022
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
A Starzer, M Preusser, A Berghoff
Therapeutic advances in medical oncology 2022
Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches
A Samad, N Meghla, Z Nain, T Karpiński, S Rahman
Cancer Immunology, Immunotherapy 2022
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
Le I, Dhandayuthapani S, Chacon J, Eiring AM, Gadad SS
Human vaccines 2022
Systematic molecular analysis of the human secretome and membrane proteome in gastrointestinal adenocarcinomas
Rehman AU, Olsson PO, Akhtar A, Padhiar AA, Liu H, Dai Y, Gong Y, Zhou Y, Khan N, Yang H, Tang L
Journal of Cellular and Molecular Medicine 2022
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
Sharma A, Virmani T, Pathak V, Sharma A, Pathak K, Kumar G, Pathak D
BioMed Research International 2022
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
Backlund CM, Holden RL, Moynihan KD, Garafola D, Farquhar C, Mehta NK, Maiorino L, Pham S, Iorgulescu JB, Reardon DA, Wu CJ, Pentelute BL, Irvine DJ
Proceedings of the National Academy of Sciences 2022
A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy
Yang Z, Huang J, Lin Y, Luo X, Lin H, Lin H, Gao J
2022
Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1
Lee HH, Hong SH, Rhee JH, Lee SE
Translational cancer research 2022
Potential of Black Phosphorus in Immune-Based Therapeutic Strategies
Dong W, Wang H, Liu H, Zhou C, Zhang X, Wang S, He L
Bioinorganic Chemistry and Applications 2022
Cancer vaccines: the next immunotherapy frontier.
Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD
2022
Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma.
Yu C, Li Q, Zhang Y, Wen ZF, Dong H, Mou Y
Frontiers in Cell and Developmental Biology 2022
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer
Geng F, Dong L, Bao X, Guo Q, Guo J, Zhou Y, Yu B, Wu H, Wu J, Zhang H, Yu X, Kong W
2022
Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.
Wirsching S, Fichter M, Cacicedo ML, Landfester K, Gehring S
International journal of molecular sciences 2022
mRNA-Based Approaches to Treating Liver Diseases.
Cacicedo ML, Limeres MJ, Gehring S
Cells 2022
Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis
Diao L, Ma L, Cheng J, Pan Y, Peng Z, Zhang L, Xu M, Li Y, Zhang X, Jiang H, Xu G, Meng F, Zhong Z, Liu M
iScience 2022
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
Karim ME, Haque ST, Al-Busaidi H, Bakhtiar A, Tha KK, Holl MM, Chowdhury EH
Archives of Pharmacal Research 2022
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F
Cancers 2022
Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine
Ke CH, Chiu YH, Huang KC, Lin CS
International journal of molecular sciences 2022
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
Ashi MO, Mami-Chouaib F, Corgnac S
2022
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
Shen Y, Yu L, Xu X, Yu S, Yu Z
2022
STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity
M Rossi, S Carboni, WD Berardino-Besson, E Riva, ML Santiago-Raber, E Belnoue, M Derouazi
Frontiers in immunology 2021
Advancing to the era of cancer immunotherapy
Y Wang, M Wang, HX Wu, RH Xu
2021
A review on the advances and challenges of immunotherapy for head and neck cancer
G Cheng, H Dong, C Yang, Y Liu, Y Wu, L Zhu, X Tong, S Wang
Cancer Cell International 2021
Exosome-Based Vaccines: History, Current State, and Clinical Trials
P Santos, F Almeida
Frontiers in immunology 2021
Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies
EG Alcaide, S Krishnarajah, F Junker
Human vaccines 2021
Therapeutic cancer vaccines
M Saxena, SH van der Burg, CJ Melief, N Bhardwaj
Nature Reviews Cancer 2021
The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
Y Liu, Z Wang, F Yu, M Li, H Zhu, K Wang, M Meng, W Zhao
International Journal of Nanomedicine 2021
Cancer-Associated Fibroblasts: Implications for Cancer Therapy
A Maia, S Wiemann
Cancers 2021
Generated SecPen_NY-ESO-1_ubiquitin-pulsed dendritic cell cancer vaccine elicits stronger and specific T cell immune responses
Y Yang, X Guo, B Hu, P He, X Jiang, Z Wang, H Zhu, L Hu, M Yu, M Feng
Acta pharmaceutica Sinica. B 2021
Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
K Rakhra, W Abraham, C Wang, KD Moynihan, N Li, N Donahue, AD Baldeon, DJ Irvine
Science Immunology 2021
Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
MK Twilhaar, L Czentner, CF van Nostrum, G Storm, JM den Haan
Pharmaceutics 2021
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
BN Aldosari, IM Alfagih, AS Almurshedi
Pharmaceutics 2021
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform
H Lauterbach, S Schmidt, K Katchar, X Qing, C Iacobucci, A Hwang, K Schlienger, U Berka, J Raguz, S Ahmadi-Erber, T Schippers, F Stemeseder, DD Pinschewer, I Matushansky, KK Orlinger
Frontiers in Oncology 2021
Lipid-Polyglutamate Nanoparticle Vaccine Platform
DV Lysebetten, A Malfanti, K Deswarte, K Koynov, B Golba, T Ye, Z Zhong, S Kasmi, A Lamoot, Y Chen, SV Herck, BN Lambrecht, NN Sanders, S Lienenklaus, SA David, MJ Vicent, SD Koker, BG Geest
ACS Applied Materials & Interfaces 2021
Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma
J He, X Fang, M Han
Frontiers in Genetics 2021
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy
JR Richardson, A Schöllhorn, C Gouttefangeas, J Schuhmacher
Cancers 2021
Cancer Vaccines, Adjuvants, and Delivery Systems
SJ Paston, VA Brentville, P Symonds, LG Durrant
Frontiers in immunology 2021
Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer
M Saillard, M Cenerenti, P Romero, C Jandus
Human vaccines 2021
Therapeutic Cancer Vaccines Revamping: Technology Advancements and Pitfalls
G Antonarelli, C Corti, P Tarantino, L Ascione, J Cortes, P Romero, EA Mittendorf, ML Disis, G Curigliano
Annals of Oncology 2021
Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures
DT Jansen, Y Dou, JW de Wilde, AM Woltman, SI Buschow
IBMS BoneKEy 2021
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
MY Lee, S Metenou, DE Brough, H Sabzevari, K Bai, C Jochems, J Schlom, CT Allen
npj Vaccines 2021
Vaccine Therapies for Cancer: Then and Now
MA Morse, WR Gwin, DA Mitchell
Targeted Oncology 2021
Low-Temperature Photothermal Therapy: Strategies and Applications
X Yi, QY Duan, FW
Research 2021
Nanomaterials for Protein Delivery in Anticancer Applications
A Yau, J Lee, Y Chen
Pharmaceutics 2021
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
CS Shemesh, JC Hsu, I Hosseini, BQ Shen, A Rotte, P Twomey, S Girish, B Wu
Molecular Therapy 2021
In situ cancer vaccination using lipidoid nanoparticles
J Chen, M Qiu, Z Ye, T Nyalile, Y Li, Z Glass, X Zhao, L Yang, J Chen, Q Xu
Science Advances 2021
Silica@zirconia Core@shell Nanoparticles for Nucleic Acid Building Block Sorption
LN Nagy, E Dhaene, MV Zele, J Mihály, S Klébert, Z Varga, KE Kövér, KD Buysser, IV Driessche, JC Martins, K Fehér
Nanomaterials 2021
A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment
A Farias, A Soto, F Puttur, CJ Goldin, S Sosa, C Gil, FA Goldbaum, PM Berguer
Scientific Reports 2021
Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
K Mochizuki, S Kobayashi, N Takahashi, K Sugimoto, H Sano, Y Ohara, S Mineishi, Y Zhang, A Kikuta
Journal of Experimental & Clinical Cancer Research 2021
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
S Feola, M Haapala, K Peltonen, C Capasso, B Martins, G Antignani, A Federico, V Pietiäinen, J Chiaro, M Feodoroff, S Russo, A Rannikko, M Fusciello, S Koskela, J Partanen, F Hamdan, SM Tähkä, E Ylösmäki, D Greco, M Grönholm, T Kekarainen, M Eshaghi, OL Gurvich, S Ylä-Herttuala, RM Branca, J Lehtiö, TM Sikanen, V Cerullo
ACS Nano 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
JH Grauslund, MO Holmström, NG Jørgensen, U Klausen, SE Weis-Banke, DE Fassi, C Schöllkopf, MB Clausen, LM Gjerdrum, MF Breinholt, JW Kjeldsen, M Hansen, S Koschmieder, N Chatain, GW Novotny, J Petersen, L Kjær, V Skov, Ö Met, IM Svane, HC Hasselbalch, MH Andersen
Frontiers in Oncology 2021
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model
K Kitagawa, M Tatsumi, M Kato, S Komai, H Doi, Y Hashii, T Katayama, M Fujisawa, T Shirakawa
Molecular Therapy — Oncolytics 2021
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
VM Leb-Reichl, M Kienzl, A Kaufmann, A Stoecklinger, B Tockner, S Kitzmueller, N Zaborsky, M Steiner, G Brachtl, L Trattner, P Kreideweiss, C Reinsch, S Panzner, R Greil, D Strunk, JW Bauer, IK Gratz, C Guttmann-Gruber, JP Hofbauer
Journal for ImmunoTherapy of Cancer 2021
Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
S van Oost, DM Meijer, ML Kuijjer, JV Bovée, NF de Miranda
Biomedicines 2021
Systemic adverse effects and toxicities associated with immunotherapy: A review
A Kichloo, M Albosta, D Dahiya, JC Guidi, M Aljadah, J Singh, H Shaka, F Wani, A Kumar, M Lekkala
World journal of clinical oncology 2021
Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
PP Naik
Dermatology and Therapy 2021
Cationic Nanoparticle-Based Cancer Vaccines
J Heuts, W Jiskoot, F Ossendorp, K van der Maaden
Pharmaceutics 2021
Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
L Tang, R Zhang, X Zhang, L Yang
Frontiers in Oncology 2021
A New Generation of Vaccines in the Age of Immunotherapy
A Addeo, A Friedlaender, E Giovannetti, A Russo, D de Miguel-Perez, O Arrieta, AF Cardona, C Rolfo
Current Oncology Reports 2021
Integrating CD4 + T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model
H Shibata, N Xu, S Saito, L Zhou, I Ozgenc, J Webb, C Fu, P Zolkind, AM Egloff, R Uppaluri
OncoImmunology 2021
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
T Cai, H Liu, S Zhang, J Hu, L Zhang
Journal of nanobiotechnology 2021
Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
P Yang, Y Peng, Y Feng, Z Xu, P Feng, J Cao, Y Chen, X Chen, X Cao, Y Yang, J Jie
Frontiers in immunology 2021
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs)
C Ragone, C Manolio, B Cavalluzzo, A Mauriello, ML Tornesello, FM Buonaguro, F Castiglione, L Vitagliano, E Iaccarino, M Ruvo, M Tagliamonte, L Buonaguro
Journal for ImmunoTherapy of Cancer 2021
Patient-reported outcomes in vaccines research: relevance for decision-making
D Curran, E Cabrera, L Nelsen
Human Vaccines & Immunotherapeutics 2021
Brain Tumor Vaccines
Lee J, Uy BR, Liau LM
Neurosurgery clinics of North America 2021
A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
MA Gleisner, C Pereda, A Tittarelli, M Navarrete, C Fuentes, I Ávalos, F Tempio, JP Araya, MI Becker, FE González, MN López, F Salazar-Onfray
Journal for ImmunoTherapy of Cancer 2020
Progress in Neoantigen Targeted Cancer Immunotherapies
XJ Han, X Ma, L Yang, Y Wei, Y Peng, X Wei
Frontiers in Cell and Developmental Biology 2020
Cellular immunotherapies for cancer
C Hayes
Irish Journal of Medical Science 2020
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy
SE Brightman, MS Naradikian, AM Miller, SP Schoenberger
Journal of leukocyte biology 2020
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
J Wischhusen, I Melero, WH Fridman
Frontiers in immunology 2020
Tumor immune response and immunotherapy in gastric cancer
Y Kwak, AN Seo, HE Lee, HS Lee
Journal of Pathology and Translational Medcine 2020
Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
V Schirrmacher
Biomedicines 2020
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
M Ralli, A Botticelli, IC Visconti, D Angeletti, M Fiore, P Marchetti, A Lambiase, M de Vincentiis, A Greco
Journal of Immunology Research 2020
Exploring the food-gut axis in immunotherapy response of cancer patients
E Russo, G Nannini, M Dinu, G Pagliai, F Sofi, A Amedei
World journal of gastroenterology : WJG 2020
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
TC Albershardt, J Leleux, AJ Parsons, JE Krull, P Berglund, J ter Meulen
npj Vaccines 2020
Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment
EK Elmahallawy, Y Mohamed, W Abdo, T Yanai
International journal of molecular sciences 2020
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
JG Pol, MJ Atherton, KB Stephenson, BW Bridle, ST Workenhe, N Kazdhan, AJ McGray, Y Wan, G Kroemer, BD Lichty
Journal for ImmunoTherapy of Cancer 2020
Selecting Target Antigens for Cancer Vaccine Development
L Buonaguro, M Tagliamonte
Human vaccines 2020
Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
Z Lu, Z Peng, C Liu, Z Wang, Y Wang, , J Li, L Shen
2020
Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imaging
KC Han, D Park, S Ju, YE Lee, SH Heo, YA Kim, JE Lee, Y Lee, KH Park, SH Park, HJ Lee, C Lee, M Jang
Scientific Reports 2020

Therapeutic Vaccines for HPV-Associated Malignancies


CS Rumfield, N Roller, ST Pellom, J Schlom, C Jochems
ImmunoTargets and Therapy 2020
Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells
P Gierlich, V Lex, A Technau, A Keupp, L Morper, A Glunz, H Sennholz, J Rachor, S Sauer, A Marcu, GU Grigoleit, M Wölfl, PG Schlegel, M Eyrich
Cancer Immunology, Immunotherapy 2020
São Paulo School of Advanced Sciences on Vaccines: an overview
S Sorgi, V Bonezi, MR Dominguez, AM Gimenez, I Dobrescu, S Boscardin, HI Nakaya, DY Bargieri, IS Soares, EL Silveira
Journal of Venomous Animals and Toxins 2020
Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations
IB Hernández, Y Yu, F Ossendorp, M Korbelik, S Oliveira
Journal of Clinical Medicine 2020
Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
R Barrett, E Puré
Current Opinion in Immunology 2020
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer
MD Kerr, DA McBride, AK Chumber, NJ Shah
Expert Opinion on Drug Discovery 2020
Co-assembled Supramolecular Nanofibers With Tunable Surface Properties for Efficient Vaccine Delivery
Z Wang, C Ren, Y Shang, C Yang, Q Guo, L Chu, J Liu
Frontiers in Chemistry 2020
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
MO Holmström, HC Hasselbalch, MH Andersen
Cancers 2020
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
B Yang, J Gao, Q Pei, H Xu, H Yu
Advanced Science 2020
IFN-Stimulated Gene 15 Is an Alarmin that Boosts the CTL Response via an Innate, NK Cell–Dependent Route
V Iglesias-Guimarais, T Ahrends, E de Vries, KP Knobeloch, A Volkov, J Borst
Journal of immunology (Baltimore, Md. : 1950) 2020
Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper Cells
G Forlani, M Shallak, F Celesti, RS Accolla
Cancers 2020
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
R Bouzid, M Peppelenbosch, SI Buschow
Cancers 2020
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
X Xie, Y Hu, T Ye, Y Chen, L Zhou, F Li, , S Wang, Y He, X Gao, W Wei, G Ma, Y Li
Nature Biomedical Engineering 2020
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
A Samad, F Ahammad, Z Nain, R Alam, RR Imon, M Hasan, S Rahman
Journal of Biomolecular Structure and Dynamics 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
N Somaiah, SP Chawla, MS Block, JC Morris, K Do, JW Kim, M Druta, KK Sankhala, P Hwu, RL Jones, S Gnjatic, S Kim-Schulze, K Tuballes, M Yishak, H Lu, A Yakovich, JT Meulen, M Chen, RT Kenney, C Bohac, SM Pollack
OncoImmunology 2020
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
TC Ende, JM Heuts, GP Gential, M Visser, MJ Graaff, NI Ho, W Jiskoot, AR Valentijn, NJ Meeuwenoord, HS Overkleeft, JD Codée, SH Burg, EM Verdegaal, GA Marel, F Ossendorp, DV Filippov
Chembiochem : a European journal of chemical biology 2020
Freeze-Drying Formulations Increased the Adenovirus and Poxvirus Vaccine Storage Times and Antigen Stabilities
Y Chen, Q Liao, T Chen, Y Zhang, W Yuan, J Xu, X Zhang
Virologica Sinica 2020
Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
RL Barrett, E Puré
eLife 2020
Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages
MK Twilhaar, L Czentner, J Grabowska, AJ Affandi, CY Lau, K Olesek, H Kalay, CF van Nostrum, Y van Kooyk, G Storm, JM den Haan
Pharmaceutics 2020
Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
L Wei, Y Zhao, X Hu, L Tang
ACS Central Science 2020
Effective pressure and treatment duration of high hydrostatic pressure to prepare melanoma vaccines
K Liu, S Yan, Z Ma, B Liu
Oncology Letters 2020
Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM)
K Karimian-Jazi, P Münch, A Alexander, M Fischer, K Pfleiderer, M Piechutta, MA Karreman, GM Solecki, AS Berghoff, M Friedrich, K Deumelandt, FT Kurz, W Wick, S Heiland, M Bendszus, F Winkler, M Platten, MO Breckwoldt
Theranostics 2020
Gastrointestinal Adverse Effects of Immunotherapeutic Agents: A Systematic Review
DS Dahiya, F Wani, JC Guidi, A Kichloo
Gastroenterology Research 2020
A supramolecular protein chaperone for vaccine delivery
Z Wang, Y Shang, Z Tan, X Li, G Li, C Ren, F Wang, Z Yang, J Liu
Theranostics 2020
Wilms' Tumor 1 (WT1): The Vaccine for Cancer
Hein KZ, Yao S, Fu S
2020
Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity
Dong S, Subramanian S, Parent KN, Chen M
Journal of Controlled Release 2020
Special Review: The future of Immunotherapy
Melief CJ
2020
Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine
Elodie Belnoue, Jean-François Mayol, Susanna Carboni, Wilma Di Berardino Besson, Eloise Dupuychaffray, Annika Nelde, Stefan Stevanovic, Marie-Laure Santiago-Raber, Paul R Walker, Madiha Derouazi
JCI Insight 2019
<Editors' Choice> Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity
Vitaly Kochin, Hiroyoshi Nishikawa
NAGOYA J MED SCI 2019
Neoantigen vaccine: an emerging tumor immunotherapy
M Peng, Y Mo, Y Wang, P Wu, Y Zhang, F Xiong, C Guo, X Wu, Y Li, X Li, G Li, W Xiong, Z Zeng
Molecular Cancer 2019
Immunotherapy for pediatric brain tumors: past and present
JB Foster, PJ Madsen, M Hegde, N Ahmed, KA Cole, JM Maris, AC Resnick, PB Storm, AJ Waanders
Neuro-Oncology 2019
Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing
M Leclerc, L Mezquita, GG Nerville, I Tihy, I Malenica, S Chouaib, F Mami-Chouaib
Frontiers in immunology 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
ZS Guo, B Lu, Z Guo, E Giehl, M Feist, E Dai, W Liu, WJ Storkus, Y He, Z Liu, DL Bartlett
Journal for ImmunoTherapy of Cancer 2019
Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans
D van Dinther, ML Venegas, H Veninga, K Olesek, L Hoogterp, M Revet, M Ambrosini, H Kalay, J Stöckl, Y van Kooyk, J den Haan
Cancers 2019
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
K Vermaelen
Frontiers in immunology 2019
Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
J Zhao, Y Chen, ZY Ding, JY Liu
Frontiers in pharmacology 2019
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
C Lhuillier, NP Rudqvist, O Elemento, SC Formenti, S Demaria
Genome Medicine 2019
Immunotherapy: breaching the barriers for cancer treatment
VG Martinez, D Park, SE Acton
Philosophical Transactions of the Royal Society B: Biological Sciences 2019
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
H Sultan, T Kumai, T Nagato, J Wu, AM Salazar, E Celis
Cancer Immunology, Immunotherapy 2019
Nanotechnology-based photoimmunological therapies for cancer
Y Li, X Li, F Zhou, A Doughty, AR Hoover, RE Nordquist, WR Chen
Cancer Letters 2019
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
C Rabu, L Rangan, L Florenceau, A Fortun, M Charpentier, E Dupré, L Paolini, C Beauvillain, E Dupel, JB Latouche, O Adotevi, N Labarrière, F Lang
OncoImmunology 2019
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
HJ Park, GY Jang, YS Kim, JH Park, SE Lee, MC Vo, JJ Lee, HD Han, ID Jung, TH Kang, YM Park
Journal for ImmunoTherapy of Cancer 2019
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
RS Accolla, E Ramia, A Tedeschi, G Forlani
Frontiers in immunology 2019
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
C Zhou, ZK Tuong, IH Frazer
Frontiers in Oncology 2019
Targeting Angiogenesis With Peptide Vaccines
MA Rahat
Frontiers in immunology 2019
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
ML Guevara, Z Jilesen, D Stojdl, S Persano
ACS Omega 2019
Mucosal Vaccination via the Respiratory Tract
Hellfritzsch, Scherließ
Pharmaceutics 2019
Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine
EI Wafa, SM Geary, KA Ross, JT Goodman, B Narasimhan, AK Salem
Nanomedicine : nanotechnology, biology, and medicine 2019
Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
S de Bruijn, S Anguille, J Verlooy, EL Smits, VF van Tendeloo, M de Laere, K Norga, ZN Berneman, E Lion
Cancers 2019
Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8+ T-Cell Response
J Liu, DK Jaijyan, Q Tang, H Zhu
International journal of molecular sciences 2019
An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation
K Krotova, A Day, G Aslanidi
Molecular Therapy — Oncolytics 2019
Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
P Sharma, NY Jang, JW Lee, BC Park, YK Kim, NH Cho
Pharmaceutics 2019
Nanoparticle cancer vaccines: design considerations and recent advances
J Liu, L Miao, J Sui, Y Hao, G Huang
Asian Journal of Pharmaceutical Sciences 2019
CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
T Ahrends, J Busselaar, TM Severson, N Bąbała, E de Vries, A Bovens, L Wessels, F van Leeuwen, J Borst
Nature Communications 2019
Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials
Kim, Lee, Eisenhut, Vliet, Kronbichler, Jeong, Shin, Gamerith
Cancers 2019
Vaccines
Jiskoot W, Kersten GF, Mastrobattista E, Slütter B
2019
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.
Mahipal A, Ejadi S, Gnjatic S, Kim-Schulze S, Lu H, Ter Meulen JH, Kenney R, Odunsi K
Cancer Immunology, Immunotherapy 2019
Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
D van Dinther, H Veninga, M Revet, L Hoogterp, K Olesek, J Grabowska, EG Borg, H Kalay, Y van Kooyk, JM den Haan
Frontiers in immunology 2018
Combination Immunotherapy: Taking Cancer Vaccines to the Next Level
JM Grenier, ST Yeung, KM Khanna
Frontiers in immunology 2018
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
A Durgeau, Y Virk, S Corgnac, F Mami-Chouaib
Frontiers in immunology 2018
Targeting Head and Neck Cancer by Vaccination
C Wang, J Dickie, RV Sutavani, C Pointer, GJ Thomas, N Savelyeva
Frontiers in immunology 2018
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
N van Montfoort, L Borst, MJ Korrer, M Sluijter, KA Marijt, SJ Santegoets, VJ van Ham, I Ehsan, P Charoentong, P André, N Wagtmann, MJ Welters, YJ Kim, SJ Piersma, SH van der Burg, T van Hall
Cell 2018
Next Generation Cancer Vaccines—Make It Personal!
A Terbuch, J Lopez
Human vaccines 2018
Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration
A Karlsson-Parra, J Kovacka, E Heimann, M Jorvid, S Zeilemaker, S Longhurst, P Suenaert
Pharmaceutical Research 2018
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms
SY Lim, H Rizos
Mammalian Genome 2018
Biomaterials for vaccine-based cancer immunotherapy
R Zhang, MM Billingsley, MJ Mitchell
Journal of Controlled Release 2018
An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells
P Wang, P Zhao, S Dong, T Xu, X He, M Chen
Theranostics 2018
Recombinant Listeria promotes tumor rejection by CD8 + T cell-dependent remodeling of the tumor microenvironment
W Deng, V Lira, TE Hudson, EE Lemmens, WG Hanson, R Flores, G Barajas, GE Katibah, AL Desbien, P Lauer, ML Leong, DA Portnoy, TW Dubensky
Proceedings of the National Academy of Sciences 2018
Trial watch: peptide-based vaccines in anticancer therapy
L Bezu, O Kepp, G Cerrato, J Pol, J Fucikova, R Spisek, L Zitvogel, G Kroemer, L Galluzzi
OncoImmunology 2018
Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
F Qiu, KW Becker, FC Knight, JJ Baljon, S Sevimli, D Shae, P Gilchuk, S Joyce, JT Wilson
Biomaterials 2018
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
S Ogino, JA Nowak, T Hamada, AI Phipps, U Peters, DA Milner, EL Giovannucci, R Nishihara, M Giannakis, WS Garrett, M Song
Gut 2018
Oral manifestations of human papillomavirus infections
S Syrjänen
European Journal of Oral Sciences 2018
Cancer immunotherapy: broadening the scope of targetable tumours
J van den Bulk, EM Verdegaal, NF de Miranda
Open Biology 2018
Metallic nanoparticles for cancer immunotherapy
ER Evans, P Bugga, V Asthana, R Drezek
Materials today (Kidlington, England) 2018
Cancer vaccine: learning lessons from immune checkpoint inhibitors
ZL Ye, Q Qian, HJ Jin, QJ Qian
Journal of Cancer 2018
mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells
B Lou, SD Koker, CY Lau, WE Hennink, E Mastrobattista
Bioconjugate Chemistry 2018
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer: A Phase 2 Clinical Trial
E Massarelli, W William, F Johnson, M Kies, R Ferrarotto, M Guo, L Feng, JJ Lee, H Tran, YU Kim, C Haymaker, C Bernatchez, M Curran, TZ Barrese, JR Canales, I Wistuba, L Li, J Wang, SH van der Burg, CJ Melief, B Glisson
JAMA Oncology 2018
A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins
HA Panahi, A Bolhassani, G Javadi, Z Noormohammadi, C Meyers
PloS one 2018
Harnessing the immune system in glioblastoma
NF Brown, TJ Carter, D Ottaviani, P Mulholland
British Journal of Cancer 2018
Hyperuricaemic UrahPlt2/Plt2 mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C
C Baey, J Yang, F Ronchese, JL Harper, MA Olszewski
PloS one 2018
Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis
B Jabbar, S Rafique, OM Salo-Ahen, A Ali, M Munir, M Idrees, MU Mirza, M Vanmeert, SZ Shah, I Jabbar, MA Rana
Frontiers in immunology 2018
Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
KD Moynihan, RL Holden, NK Mehta, C Wang, MR Karver, J Dinter, S Liang, W Abraham, MB Melo, AQ Zhang, N Li, SL Gall, BL Pentelute, DJ Irvine
Cancer immunology research 2018
Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine
P Probst, M Stringhini, D Ritz, T Fugmann, D Neri
Clinical cancer research 2018
Is immunotherapy here to stay in multiple myeloma?
P Rodríguez-Otero, B Paiva, M Engelhardt, F Prósper, JF san Miguel
Haematologica 2017
The Antitumor Effects of Vaccine-Activated CD8 + T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells
S Wu, W Zhu, Y Peng, L Wang, Y Hong, L Huang, D Dong, J Xie, T Merchen, E Kruse, ZS Guo, D Bartlett, N Fu, Y He
Cancer immunology research 2017
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”
M Melzer, A Lopez-Martinez, J Altomonte
Biomedicines 2017
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
L Huang, Z Wang, C Liu, C Xu, RM Mbofung, JA McKenzie, H Khong, P Hwu, W Peng
Oncogene 2017
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
MC Brown, EK Holl, D Boczkowski, E Dobrikova, M Mosaheb, V Chandramohan, DD Bigner, M Gromeier, SK Nair
Science Translational Medicine 2017
Rationale for stimulator of interferon genes–targeted cancer immunotherapy
TR Vargas, I Benoit-Lizon, L Apetoh
European Journal of Cancer 2017
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
H Sadozai, T Gruber, RE Hunger, M Schenk
Frontiers in immunology 2017
Personalized peptide vaccines and their relation to other therapies in urological cancer
T Kimura, S Egawa, H Uemura
Nature Reviews Urology 2017
Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8 + T cells
T Tršan, K Vuković, P Filipović, AL Brizić, NA Lemmermann, K Schober, DH Busch, WJ Britt, M Messerle, A Krmpotić, S Jonjić
European Journal of Immunology 2017
Elements of cancer immunity and the cancer–immune set point
DS Chen, I Mellman
Nature 2017
Beyond checkpoint inhibition – Immunotherapeutical strategies in combination with radiation
F Eckert, US Gaipl, G Niedermann, M Hettich, K Schilbach, SM Huber, D Zips
Clinical and Translational Radiation Oncology 2017
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Y Min, KC Roche, S Tian, MJ Eblan, KP McKinnon, JM Caster, S Chai, LE Herring, L Zhang, T Zhang, JM DeSimone, JE Tepper, BG Vincent, JS Serody, AZ Wang
Nature Nanotechnology 2017
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
ST Koshy, AS Cheung, L Gu, AR Graveline, DJ Mooney
Advanced Biosystems 2017
Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination
M Rad-Malekshahi, MF Fransen, M Krawczyk, M Mansourian, M Bourajjaj, J Chen, F Ossendorp, WE Hennink, E Mastrobattista, M Amidi
Molecular Pharmaceutics 2017
Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
I Téguété, A Dolo, K Sangare, A Sissoko, M Rochas, S Beseme, K Tounkara, S Yekta, AS de Groot, OA Koita, ML Tornesello
PloS one 2017
Listening to each other: Infectious disease and cancer immunology
RE Vance, MJ Eichberg, DA Portnoy, DH Raulet
Science Immunology 2017
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies
A Aitken, D Roy, MC Bourgeois-Daigneault
Biomedicines 2017
Biomaterials Strategies for Generating Therapeutic Immune Responses
SH Kelly, LS Shores, NL Votaw, JH Collier
Advanced Drug Delivery Reviews 2017
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)
DA Hayes, DA Kunde, RL Taylor, SB Pyecroft, SS Sohal, ET Snow, A Ahmad
PloS one 2017
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination
KF Gerer, M Erdmann, SR Hadrup, R Lyngaa, LM Martin, RE Voll, B Schuler-Thurner, G Schuler, N Schaft, S Hoyer, J Dörrie
Therapeutic advances in medical oncology 2017
Expression von Cancer-Testis(CT)-Antigenen in Melanomen des Kindes- und Jugendalters
N Behrendt, T Schultewolter, K Busam, D Frosina, G Spagnoli, A Jungbluth
Der Pathologe 2017
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy
S Smola, C Trimble, PL Stern
Therapeutic advances in vaccines 2017
Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12–13 May 2017
PL Stern
Therapeutic advances in vaccines 2017
Epigenetic Regulation of Dendritic Cell Development and Function:
Y Tian, L Meng, Y Zhang
The Cancer Journal 2017
Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice
KP Fabian, N Chi-Sabins, JL Taylor, R Fecek, A Weinstein, WJ Storkus
OncoImmunology 2017
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Z Hu, PA Ott, CJ Wu
Nature Reviews Immunology 2017
Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
AV Kroll, RH Fang, Y Jiang, J Zhou, X Wei, CL Yu, J Gao, BT Luk, D Dehaini, W Gao, L Zhang
Advanced materials (Deerfield Beach, Fla.) 2017
Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome?: Targeting the Right Antigens in the Right Patients
SP Schoenberger
Cold Spring Harbor perspectives in biology 2017
Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy
W Zhang, M An, , H Liu
Bioconjugate Chemistry 2017
Metabolic regulation of immune responses: therapeutic opportunities
Nadine Assmann, David Finlay
Journal of Clinical Investigation 2016
Profiling cancer-testis antigens in non-small cell lung cancer
Dijana Djureinovic, Björn Hallström, Masafumi Horie, Johanna Mattsson, Linnea La Fleur, Linn Fagerberg, Hans Brunnström, Cecilia Lindskog, Katrin Madjar, Jörg Rahnenführer, Simon Ekman, Elisabeth Ståhle, Hirsh Koyi, Eva Brandén, Karolina Edlund, Jan Hengstler, Mats Lambe, Akira Saito, Johan Botling, Frederik Frederik Pontén, Mathias Mathias Uhlén, Patrick Micke
JCI Insight 2016
Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation
E Simanovich, V Brod, MM Rahat, E Drazdov, M Walter, J Shakya, MA Rahat
OncoImmunology 2016
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
A Redeker, R Arens
Frontiers in immunology 2016
Immune targets and neoantigens for cancer immunotherapy and precision medicine
RF Wang, HY Wang
Cell Research 2016
Combinatorial approach to cancer immunotherapy: strength in numbers
AE Vilgelm, DB Johnson, A Richmond
Journal of leukocyte biology 2016
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy
HS Hong, SD Koch, B Scheel, U Gnad-Vogt, A Schröder, KJ Kallen, V Wiegand, L Backert, O Kohlbacher, I Hoerr, M Fotin-Mleczek, JM Billingsley
OncoImmunology 2016
Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma
P Zolkind, GP Dunn, T Lin, M Griffith, OL Griffith, R Uppaluri
Oral Oncology 2016
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
I Siddiqui, M Erreni, M Brakel, R Debets, P Allavena
Journal for ImmunoTherapy of Cancer 2016
Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide
IF Voutsas, EA Anastasopoulou, P Tzonis, M Papamichail, SA Perez, CN Baxevanis
Journal for ImmunoTherapy of Cancer 2016
Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors
S Karaki, M Anson, T Tran, D Giusti, C Blanc, S Oudard, E Tartour
Human vaccines 2016
Monitoring of the Immune Dysfunction in Cancer Patients
S Santegoets, M Welters, S der Burg
Human vaccines 2016
B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
VT Colluru, DG McNeel
Oncotarget 2016
Vaccines for established cancer: overcoming the challenges posed by immune evasion
SH van der Burg, R Arens, F Ossendorp, T Hall, CJ Melief
Nature Reviews Cancer 2016
MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity
MR Collinson-Pautz, KM Slawin, JM Levitt, DM Spencer, H Shiku
PloS one 2016
Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
Y Ma, X Chu, Y Li, Q Long, Y Xia, Y Yao, W Sun, W Huang, X Yang, C Liu
International Journal of Nanomedicine 2016
Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons
I Castro, TM Giret, DM Magnani, HS Maxwell, O Umland, JK Perry, JK Pecotte, KM Brasky, GN Barber, RC Desrosiers, DI Watkins, SR Ross
Journal of virology 2016
Biomaterials for enhancing anti-cancer immunity
ST Koshy, DJ Mooney
Current Opinion in Biotechnology 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P Vici, L Pizzuti, L Mariani, G Zampa, D Santini, LD Lauro, T Gamucci, C Natoli, P Marchetti, M Barba, M Maugeri-Saccà, D Sergi, F Tomao, E Vizza, SD Filippo, F Paolini, G Curzio, G Corrado, A Michelotti, G Sanguineti, A Giordano, RD Maria, A Venuti
Expert Review of Vaccines 2016
Immunogenic FEAT protein circulates in the bloodstream of cancer patients
Y Li, K Kobayashi, MM Mona, C Satomi, S Okano, H Inoue, K Tani, A Takahashi
Journal of Translational Medicine 2016
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer
WC Watt, DL Cecil, ML Disis
Seminars in Immunopathology 2016
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
MA Oberli, AM Reichmuth, JR Dorkin, MJ Mitchell, OS Fenton, A Jaklenec, DG Anderson, R Langer, D Blankschtein
Nano letters 2016
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression
G Yu, Y Li, Z Cui, NP Morris, AD Weinberg, BA Fox, WJ Urba, L Wang, HM Hu
Scientific Reports 2016
Myeloid-derived suppressor cells and tumor escape from immune surveillance
V Umansky, C Blattner, V Fleming, X Hu, C Gebhardt, P Altevogt, J Utikal
Seminars in Immunopathology 2016
Cancer Immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
Journal of Clinical Investigation 2015
Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
PR Walker, E Belnoue, PY Dietrich, M Derouazi
OncoImmunology 2015

← Previous 1 2 … 9 10 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 2 X users
Referenced in 10 patents
Referenced in 10 Wikipedia pages
688 readers on Mendeley
See more details